Search for: "Dominic Adair" Results 1 - 20 of 20
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Sep 2016, 1:03 am by Vanessa Rieu
Moderator Dominic Adair (Partner, Bristows (UK)) led his panellists Fritz Reiter (Regulatory CMC Team Leader, Sandoz GmbH (AT)), Prof. [read post]
18 Oct 2017, 7:27 am by Brian Cordery
Brian Corderyby Dominic Adair The panel sessions of AIPPI Sydney 2017 opened in style with a blockbuster trade secrets double session. [read post]
17 Oct 2017, 5:47 pm
 The busy Dominic Adair returned to explore issues relating to wearable devices; not just Fitbits and the like, but hearing aids and pain adjustment technology. [read post]
1 Mar 2018, 7:41 am by Dominic Adair
Dominic AdairThe afternoon of the first day of C5’s Pharma & Biotech conference in Amsterdam (27 February 2018) concluded with a lively panel session on biosimilars. [read post]
18 Oct 2017, 7:32 am by Brian Cordery
The mischief the plausibility requirement is seeking to cure, explained Dominic Adair (Bristows), is the allowance of speculative or “armchair” inventing, but Adair also cautioned against prohibiting all forms of “armchair inventions” if there is a good invention behind it. [read post]
10 Apr 2017, 8:18 am
The event was introduced by Dominic Adair, with presentations from Michael Silverleaf QC, Ravi Srinivasan and Mark Brealey QC. [read post]
27 Sep 2018, 7:18 am
Dominic Adair (Bristows) explained that the UK Courts looks backwards at the defendants' behavior and will look as to whether the  acts of the defendant amounted to an unwarranted head start/commercial advantage. [read post]
15 Oct 2017, 7:59 pm
 Dominic Adair explained that “plausibility” is directed at preventing speculative claiming and so deprive others of freedom to operate. [read post]
17 Sep 2014, 9:24 am
The final speaker, Dominic Adair (Bristows, UK) brought the audience back to the present market conditions of low market penetration. [read post]
22 Sep 2016, 5:32 pm
Vanessa reports:"In the second Pharma session on Monday, Moderator Dominic Adair (Bristows, UK) and panellists Fritz Reiter, (Regulatory CMC Team Leader, Sandoz GmbH, AT), Prof. [read post]
11 Jun 2014, 8:13 pm
  Partner Dominic Adair was stood ready to be called in as technical judge if required.What happened in May when proceedings were commenced? [read post]
29 Nov 2016, 7:59 pm by Daniel Shaviro
 But Bob Frank, in terms that he once nicely explained in an NYT column, invoked the work of James Duesenberry, a Harvard economist whose model for how people make consumption choices dominated the economics field & textbooks, because it nicely explained actual observed behavior, until Milton Friedman's permanent income hypothesis wholly supplanted it. [read post]
1 May 2008, 6:08 am
  Here is the abstract:It is widely accepted that legal formalist views dominated at the turn of the last century: judges, legal academics, and lawyers purportedly believed that law was comprehensive, gapless, and logically ordered, and believed that judges reasoned mechanically or deductively from this body of law to produce right answers in individual cases. [read post]
12 Sep 2012, 12:04 pm by David Bernstein
Sunstein’s work quickly came to dominate legal scholars’ understanding of Lochner, but constitutional historians have properly dismissed Sunstein’s work on Lochner as ahistorical. [read post]
29 Mar 2018, 5:46 am
 Next Dominic Adair (Bristows LLP) complained very politely about the steps which, following MedImmune v Novartis, patent litigators take to try to minimise hindsight bias when working with experts. [read post]
15 Jul 2022, 6:30 am by Mark Graber
Ferguson (1896) to a state law mandating segregation on street cars and insisted in Adair v. [read post]
23 Sep 2014, 4:38 am
Key speeches were given by Masahisa Yamaguchi (Chugai Pharmaceutical Co, Japan), who provided a concise and helpful summary of the biosimilars landscape from both US and EU standpoints, Agnes Klein (Health Canada), who explained the regulatory framework for drugs and biologics in Canada under the Food and Drugs Act, Mary Padbury (Ashurst, Australia) who spoke of the need of some context for the current slow growth rate of biosimilars in the global market, and Dominic… [read post]
28 Mar 2013, 1:00 pm by Michael Froomkin
The event was moderated by Perry Adair, the chair-elect of the CG Chamber of Commerce, who explained how the clickers would work, and admonished the audience to maintain “decorum” i.e. not to boo, heckle or the like. [read post]
28 Mar 2019, 8:56 am by Ronald Collins
The following is a series of questions posed by Ronald Collins to Stephen Budiansky concerning Budiansky’s book “Oliver Wendell Holmes: A Life in War, Law, and Ideas” (W.W. [read post]
As Benjamin Friedman, the noted Professor of Political Economy at Harvard put it, “By now there are few people who do not acknowledge that the major American financial institutions and the markets they dominate turn out to have served the country badly in recent years. [read post]